Show Notes
Bakul Patel is the director of the FDA's Digital Health Center of Excellence. In this interview, he shares his perspective on approving AI systems. He discusses how the FDA is evolving to keep up with the medical AI market, and he addresses key ethical concerns such as equity and access.
Pranav and Adriel first give an overview on the FDA's premarket pathways for medical devices. The interview with Bakul starts at 8:56. If you like what you hear, let a friend know, subscribe wherever you get your podcasts, and connect with us on Twitter @AIHealthPodcast.
More from The AI Health Podcast
Dr. George Church is a Professor of Genetics at Harvard Medical School and a co-founder of multiple biotech companies. In this wide-ranging interview, he speaks about his work on de-extinction, his vision of a future without age-related illness, and his AI-powered startups.
Karandeep Singh, MD, MMSc, is an Assistant Professor of Learning Health Sciences, Internal Medicine, Urology, and Information at the University of Michigan. He speaks with us about bridging the gap between academia and practice and discusses how the University of Michigan deploys and rigorously evaluates machine learning models in real clinical practice.
Luis Voloch is Co-Founder and Chief Technology Officer at Immunai, which is applying AI to immunology, genomics and drug discovery. He speaks with us about how Immunai is using AI to build a comprehensive, top-of-the-tree view of the immune system.
Dr. Suchi Saria is the Founder and CEO of Bayesian Health, the John C. Malone Associate Professor of computer science, statistics, and health policy, and the Director of the Machine Learning and Healthcare Lab at Johns Hopkins University. She speaks with us on how Bayesian Health uses insights from electronic health records to detect diseases and improve patient outcomes.
Dr. Panch is a primary care physician, the Co-Founder of Wellframe, and an instructor at the Harvard T.H. Chan School of Public Health. He speaks with us about Wellframe's work on demystifying complex care regimens, providing personalized support to patients, and understanding social issues affecting healthcare. He also discusses entrepreneurship strategies, the role of academic research, and the future of medical AI regulation.